| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.53B | 1.57B | 1.91B | 2.25B | 2.17B | 1.85B |
| Gross Profit | 382.49M | 406.39M | 506.06M | 602.14M | 560.32M | 440.64M |
| EBITDA | -5.95M | -3.54M | 11.46M | 115.61M | 96.00M | 32.34M |
| Net Income | -33.85M | -125.75M | -14.17M | 62.27M | 61.63M | -141.84M |
Balance Sheet | ||||||
| Total Assets | 672.78M | 675.38M | 899.38M | 1.02B | 1.03B | 980.58M |
| Cash, Cash Equivalents and Short-Term Investments | 21.90M | 22.54M | 61.88M | 72.05M | 49.90M | 62.51M |
| Total Debt | 110.10M | 66.53M | 61.34M | 62.56M | 67.02M | 68.73M |
| Total Liabilities | 367.59M | 360.02M | 441.51M | 523.09M | 540.16M | 543.39M |
| Stockholders Equity | 305.19M | 315.36M | 457.87M | 496.31M | 493.07M | 437.19M |
Cash Flow | ||||||
| Free Cash Flow | -54.71M | -41.21M | 3.48M | 89.88M | -14.57M | 125.47M |
| Operating Cash Flow | -34.91M | -17.06M | 34.75M | 120.50M | 20.44M | 152.53M |
| Investing Cash Flow | -16.93M | -2.45M | -32.32M | -20.95M | -16.22M | -34.41M |
| Financing Cash Flow | 48.55M | -17.09M | -37.58M | -64.69M | -19.13M | -92.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $152.63M | 21.79 | 11.08% | 2.55% | -12.65% | 368.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $57.34M | -7.36 | -14.43% | 41.67% | -36.79% | -507.05% | |
56 Neutral | $82.23M | -867.50 | -0.08% | ― | 1.24% | 97.14% | |
50 Neutral | $79.22M | -5.45 | -12.89% | ― | -9.13% | -1032.39% | |
48 Neutral | $144.01M | -5.35 | -8.91% | ― | -5.37% | 75.32% | |
46 Neutral | $323.36M | -2.15 | -13.11% | 3.53% | 0.46% | -477.90% |
On January 12, 2026, TrueBlue, Inc. appointed Brian Capone as Senior Vice President and Chief Accounting Officer, succeeding Carl Schweihs in the principal accounting role while Schweihs remains Executive Vice President and Chief Financial Officer. Capone brings extensive experience from prior senior accounting and controller positions at Avaya, embecta Corp., Cantel Medical, Stryker, and Quest Diagnostics, and his employment terms include a $315,000 base salary, performance-based equity and cash bonus opportunities starting in 2027, and a one-time cash award vesting over four years, underscoring TrueBlue’s emphasis on strengthening its financial leadership and governance without any disclosed conflicts of interest or related-party arrangements.
The most recent analyst rating on (TBI) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Trueblue stock, see the TBI Stock Forecast page.
On January 8, 2025, TrueBlue issued a statement responding to director nominations from EHS Management, asserting that its existing strategic plan is improving financial results and positioning the company for sustainable, profitable growth in the staffing market. The company highlighted recent board refresh efforts, including the appointments of William Greenblatt and William Seward and the planned retirement of two current directors by or before the 2026 annual meeting, a process it said was informed by extensive shareholder engagement and endorsed by its largest shareholder. TrueBlue emphasized that its current board brings deep industry, operational, and financial expertise aligned with its technology-led workforce strategy, criticized EHS’s planned proxy contest as costly and disruptive, and told investors no immediate action is required ahead of the company’s forthcoming proxy materials for the 2026 shareholder meeting.
The most recent analyst rating on (TBI) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Trueblue stock, see the TBI Stock Forecast page.
On December 2, 2025, TrueBlue, Inc. announced the appointment of William Greenblatt and William Seward to its board of directors, effective January 5, 2026. This decision follows an extensive search process and reflects TrueBlue’s commitment to strengthening its board with experienced leaders to support its strategic growth and transformation. Mr. Greenblatt, a pioneer in background screening, and Mr. Seward, a seasoned executive in logistics and supply chain, bring valuable expertise to the board. The appointments are part of TrueBlue’s ongoing efforts to evolve its board composition, enhance operational oversight, and align with shareholder feedback, with two current directors expected to step down by the 2026 Annual Meeting of Shareholders.
The most recent analyst rating on (TBI) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Trueblue stock, see the TBI Stock Forecast page.
TrueBlue reported its third-quarter 2025 financial results, highlighting a 13% increase in revenue to $431 million compared to the same period last year. The company reduced its net loss to $2 million from $8 million in the prior year, with strategic growth in skilled businesses and digital transformation efforts contributing to improved performance. TrueBlue’s focus on high-growth markets and optimizing its sales function aims to drive sustainable, profitable growth and enhance shareholder value.
The most recent analyst rating on (TBI) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Trueblue stock, see the TBI Stock Forecast page.